Protopic Ointment in Children Atopic Eczema
NCT00689832 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 487
Last updated 2014-09-01
Summary
Children with atopic eczema and a poor response to topical corticosteroid applied either Protopic or Fluticasone ointment twice a day for 3 weeks. They could continue during 3 more weeks once a day if needed.
Conditions
- Dermatitis, Atopic
Interventions
- DRUG
-
Tacrolimus 0.03%
ointment
- DRUG
-
Fluticasone 0.005%
ointment
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Central Contact · Astellas Pharma Europe B.V.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-02-29
- Primary Completion
- 2005-08-31
- Completion
- 2005-08-31
Countries
- France
Study Locations
More Related Trials
-
A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis
NCT00666302 ·Status: COMPLETED ·Phase: PHASE4
-
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
NCT00475605 ·Status: TERMINATED
-
Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis
NCT00691262 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis
NCT00691145 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment
NCT00480896 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis
NCT00833079 ·Status: COMPLETED ·Phase: PHASE1
-
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
NCT02601703 ·Status: COMPLETED ·Phase: PHASE3
-
Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis
NCT00560326 ·Status: COMPLETED ·Phase: PHASE2
-
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
NCT01745159 ·Status: COMPLETED ·Phase: PHASE4
-
Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis
NCT00801957 ·Status: COMPLETED ·Phase: PHASE2
-
Protopic Adherence and Efficacy in Korean Eczema Patient
NCT02126176 ·Status: COMPLETED
-
Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis
NCT02004860 ·Status: COMPLETED ·Phase: PHASE3
-
Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis
NCT00535691 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
NCT06807268 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients
NCT00523952 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
NCT06311682 ·Status: RECRUITING ·Phase: PHASE3
-
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
NCT06807281 ·Status: RECRUITING ·Phase: PHASE3
-
Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis
NCT03614221 ·Status: COMPLETED ·Phase: PHASE2
-
Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis
NCT00121381 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic Dermatitis
NCT01915914 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment
NCT00480610 ·Status: COMPLETED ·Phase: PHASE3
-
Short Term Growth in Children With Atopic Dermatitis
NCT00236106 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Evaluate the Effect of a Probiotic Mixture in the Treatment of Atopic Dermatitis in Children
NCT05443490 ·Status: TERMINATED ·Phase: NA
-
Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children
NCT01772056 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy of Combining Topical Antibiotic/Steroid/Moisturizer Therapy Compared to Active Comparator in Atopic Dermatitis.
NCT03052348 ·Status: UNKNOWN ·Phase: NA